ULAB03012 / LEO / Richard Burack
Basic Study Information
Purpose:
The goal of this infrastructure grant is to establish and maintain a cohort of over
12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research
that identifies clinical (including co-morbid diseases), epidemiologic (including
lifestyle and other exposures), host genetic, tumor, and treatment factors, as well
as the interaction among these factors, on short and long-term outcomes. These efforts
will identify new approaches to improve the survival and well-being of NHL patients.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Walter Burack
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search